Global Preimplantation Genetic Testing Market

1 INTRODUCTION OF GLOBAL PREIMPLANTATION GENETIC TESTING MARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL PREIMPLANTATION GENETIC TESTING MARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY TECHNOLOGY
5.1 Overview
5.2 Next-Generation Sequencing
5.3 Polymerase Chain Reaction
5.4 Fluorescence in Situ Hybridization
5.5 Comparative Genomic Hybridization
5.6 Single-Nucleotide Polymorphism

6 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY PROCEDURE TYPE
6.1 Overview
6.2 Preimplantation Genetic Screening
6.3 Preimplantation Genetic Diagnosis

7 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY APPLICATION
7.1 Overview
7.2 Aneuploidy
7.3 Structural Chromosomal Abnormalities
7.3.1 Translocations
7.3.2 Deletions
7.3.3 Duplications
7.3.4 Inversions
7.4 Single Gene Disorders
7.5 X-Linked Disorders
7.6 HLA Typing
7.7 Gender Identification

8 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY PRODUCTS AND SERVICES
8.1 Overview
8.2 Reagents and Consumables
8.3 Instruments
8.4 Software and Services

9 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY END USER
9.1 Overview
9.2 Maternity Centers & Fertility Clinics
9.3 Hospitals, Diagnostic Labs, and Service Providers
9.4 Research Laboratories & Academic Institutes

10 GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY GEOGRAPHY
10.1 Overview
10.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.2.1 U.S.
10.2.2 Canada
10.2.3 Mexico
10.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Rest of Europe
10.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia Pacific
10.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
10.5.1 Brazil
10.5.2 Argentina
10.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

11 GLOBAL PREIMPLANTATION GENETIC TESTING MARKETCOMPETITIVE LANDSCAPE
11.1 Overview
11.2 Company Market Share
11.3 Vendor Landscape
11.4 Key Development Strategies

12 COMPANY PROFILES
12.1 Illumina, Inc.
12.1.1 Overview
12.1.2 Financial Performance
12.1.3 Product Outlook
12.1.4 Key Developments

12.2 Thermo Fisher Scientific Inc.
12.2.1 Overview
12.2.2 Financial Performance
12.2.3 Product Outlook
12.2.4 Key Developments

12.3 Agilent Technologies, Inc.
12.3.1 Overview
12.3.2 Financial Performance
12.3.3 Product Outlook
12.3.4 Key Developments

12.4 Perkinelmer, Inc.
12.4.1 Overview
12.4.2 Financial Performance
12.4.3 Product Outlook
12.4.4 Key Developments

12.5 Coopersurgical, Inc.
12.5.1 Overview
12.5.2 Financial Performance
12.5.3 Product Outlook
12.5.4 Key Developments

12.6 Abbott Laboratories
12.6.1 Overview
12.6.2 Financial Performance
12.6.3 Product Outlook
12.6.4 Key Developments

12.7 Natera, Inc.
12.7.1 Overview
12.7.2 Financial Performance
12.7.3 Product Outlook
12.7.4 Key Developments

12.8 Rubicon Genomics
12.8.1 Overview
12.8.2 Financial Performance
12.8.3 Product Outlook
12.8.4 Key Developments

12.9 Oxford Gene Technology
12.9.1 Overview
12.9.2 Financial Performance
12.9.3 Product Outlook
12.9.4 Key Developments

12.10 Yikon Genomics
12.10.1 Overview
12.10.2 Financial Performance
12.10.3 Product Outlook
12.10.4 Key Developments

12.11 Scigene
12.11.1 Overview
12.11.2 Financial Performance
12.11.3 Product Outlook
12.11.4 Key Developments

12.12 Beijing Genomics Institute
12.12.1 Overview
12.12.2 Financial Performance
12.12.3 Product Outlook
12.12.4 Key Developments

12.13 Good Start Genetics, Inc.
12.13.1 Overview
12.13.2 Financial Performance
12.13.3 Product Outlook
12.13.4 Key Developments

12.14 Invicta Genetics
12.14.1 Overview
12.14.2 Financial Performance
12.14.3 Product Outlook
12.14.4 Key Developments

12.15 Combimatrix Corporation
12.15.1 Overview
12.15.2 Financial Performance
12.15.3 Product Outlook
12.15.4 Key Developments

12.16 Genea Limited
12.16.1 Overview
12.16.2 Financial Performance
12.16.3 Product Outlook
12.16.4 Key Developments

12.17 Progenesis
12.17.1 Overview
12.17.2 Financial Performance
12.17.3 Product Outlook
12.17.4 Key Developments

13 Appendix
13.1 Related Reports